Newswise Infants with Batten disease, a rare but fatal neurological disorder, appear healthy at birth. But within a few short years, the illness takes a heavy toll, leaving children blind, speechless and paralyzed. Most die by age 5. <\/p>\n
There are no effective treatments for the disease, which can also strike older children. And several therapeutic approaches, evaluated in mouse models and in young children, have produced disappointing results. <\/p>\n
But now, working in mice with the infantile form of Batten disease, scientists at Washington University School of Medicine in St. Louis and Kings College London have discovered dramatic improvements in life span and motor function by treating the animals with gene therapy and bone marrow transplants. <\/p>\n
The results are surprising, the researchers say, because the combination therapy is far more effective than either treatment alone. Gene therapy was moderately effective in the mice, and bone marrow transplants provided no benefit, but together the two treatments created a striking synergy. <\/p>\n
The research is reported online in the Annals of Neurology. <\/p>\n
Until now, this disease has been refractory to every therapy that has been thrown at it, says senior author Mark Sands, PhD, professor of medicine and of genetics at the School of Medicine. The results are the most hopeful to date, and they open up a new avenue of research to find effective therapies to fight this devastating disease. <\/p>\n
The combination therapy did not cure the disease, the scientists caution, but mice that received both treatments experienced significant, lasting benefits. <\/p>\n
Mice that got gene therapy and a bone marrow transplant lived nearly 18.5 months, more than double the lifespan of untreated mice with the disease. (Healthy laboratory mice live about 24 months.) And for a significant portion of their lives, motor skills in mice that got both therapies were indistinguishable from those in normal, healthy mice. <\/p>\n
While bone marrow transplants carry significant risks, especially in children, the researchers say they may be able to combine gene therapy with another treatment to achieve the same results. This same approach potentially could be used to treat other forms of Batten disease. <\/p>\n
Batten disease is an inherited genetic disorder that strikes fewer than five of every 100,000 U.S. children but is slightly more common in northern Europe. There are several forms of the disease, diagnosed at different ages, and all are related to the inability of cells to break down and recycle proteins. <\/p>\n<\/p>\n
See more here: Newswise Infants with Batten disease, a rare but fatal neurological disorder, appear healthy at birth. But within a few short years, the illness takes a heavy toll, leaving children blind, speechless and paralyzed Continue reading
\nCombination Treatment in Mice Shows Promise for Fatal Neurological Disorder in Kids<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"